28/07/2022
Camelpox is the only camel disease included in the OIE’s list of reportable diseases. A chapter on camelpox has been recently added to the OIE’s manual of terrestrial animal diseases, following its endorsement by OIE’s assembly during the general session of May 2014. A special research interest in camelpox has resulted in numerous publications on different aspects of the disease and the causative virus. This is mainly attributable to the resemblance of the CMLV to small poxvirus (Baxby 1974). Interestingly, the CMLV is recently becoming the subject for studies on antiviral therapies (Duraffour et al. 2014), cellular ion channel analysis, and apoptosis.
Camelpox is a highly contagious skin disease and the most frequent infectious viral disease of the camelids that occurs in almost every country in which camel husbandry is practiced (Fig.20.1). Outbreaks have been reported in Asia (Bahrain, Iran, Iraq, Oman, Saudi Arabia, the UAE, Yemen, Syria, Afghanistan, southern parts of Russia and India, and Pakistan) and in Africa (Algeria, Egypt, Ethiopia, Kenya, Mauritania, Morocco, Niger, Somalia, and Sudan). The disease is endemic in these countries, and a pattern of sporadic outbreaks occurs with a rise in the seasonal incidence usually during the rainy season (OIE 2008). The disease was recently reported from Saudi Arabia (Yousif 2011), India (Bhanuprakash et al. 2010; Bera et al. 2011), Ethiopia (Ayelet et al. 2013), and Iran (Mosadeghhesari et al. 2014).